
VERIGRAFT and TFS HealthScience partner on pivotal Phase II/III trial of personalized tissue-engineered vein for chronic venous insufficiency
VERIGRAFT and TFS HealthScience partner on pivotal Phase II/III trial of personalized tissue-engineered vein for chronic venous insufficiency

Our 2025 sustainability year in review: the highlights
Our 2025 sustainability year in review: the highlights

Europe’s clinical development landscape: does the EU hold a busted flush or a full house?
Europe’s clinical development landscape: does the EU hold a busted flush or a full house?

TFS HealthScience Recognized with B Score in 2025 CDP Climate Change Assessment
TFS HealthScience Recognized with B Score in 2025 CDP Climate Change Assessment

Expanding the Frontiers of Neuroscience: TFS Strengthens Its Gene Therapy Portfolio in Neurodegenerative Diseases
Expanding the Frontiers of Neuroscience: TFS Strengthens Its Gene Therapy Portfolio in Neurodegenerative Diseases

TFS HealthScience Secures SBTi Validation, Advancing Its Commitment to a Net-Zero Future
TFS HealthScience Secures SBTi Validation, Advancing Its Commitment to a Net-Zero Future

TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model